Literature DB >> 10493980

Prevalence of the C282Y and H63D polymorphisms in a multi-ethnic control population.

D S Marshall1, D R Linfert, G J Tsongalis.   

Abstract

Recently a candidate gene for hereditary hemo-chromatosis, HFE, was identified. The finding raises the possibility for genetic testing to provide earlier detection and more complete genotypic evaluation of hemochromatosis affected individuals. We determined the frequency of the HFE polymorphisms, C282Y and H63D, in a randomly selected multi-ethnic control population for establishment of a hemochromatosis genetic testing program. Prevalence was determined by PCR amplification and restriction enzyme digestion of HFE in 100 Caucasians, 100 Hispanics, and 56 African Americans. Heterozygosity for C282Y was detected in 8% of Caucasians, 3% of Hispanics, and 2% of African Americans. Homozygosity for C282Y was detected in 1% of Caucasians. Heterozygosity for H63D was detected in 24% of Caucasians, 15% Hispanics, and 3.5% of African Americans. Homozygosity for H63D was present in 4% of Caucasians and 1% of Hispanics. One Hispanic case was double heterozygous for C282Y and H63D. These results indicate the highest prevalence of C282Y and H63D in the Caucasian population. Additionally, we demonstrate C282Y and H63D polymorphisms in our Hispanic and African American populations, groups in which prevalence rates remain less defined. Our results support the need for thorough interpretation of genetic results for hereditary hemochromatosis in various ethnic populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493980     DOI: 10.3892/ijmm.4.4.389

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

Review 1.  Population screening for hemochromatosis: has the time finally come?

Authors:  J C Barton; R T Acton
Journal:  Curr Gastroenterol Rep       Date:  2000-02

2.  Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data.

Authors:  Sang Y Lee; Junjia Zhu; Anna C Salzberg; Bo Zhang; Dajiang J Liu; Joshua E Muscat; Sara T Langan; James R Connor
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

3.  Living the best of both worlds: A personal scientific journey.

Authors:  Gregory J Tsongalis
Journal:  FASEB Bioadv       Date:  2021-11-05

4.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

5.  The role of HFE genotype in macrophage phenotype.

Authors:  Anne M Nixon; Elizabeth Neely; Ian A Simpson; James R Connor
Journal:  J Neuroinflammation       Date:  2018-02-01       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.